Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Maximo Rivero-Ayerza"'
Autor:
Jeroen Dauw, Pieter Martens, Petra Nijst, Evelyne Meekers, Sébastien Deferm, Henri Gruwez, Maximo Rivero-Ayerza, Hugo Van Herendael, Laurent Pison, Dieter Nuyens, Matthias Dupont, Wilfried Mullens
Publikováno v:
EP Europace. 24:1276-1283
Aims The aim of this study is to evaluate whether the MADIT-ICD benefit score can predict who benefits most from the addition of implantable cardioverter-defibrillator (ICD) to cardiac resynchronization therapy (CRT) in real-world patients with heart
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 6, Iss 4, Pp 202-213 (2006)
Magnetic assisted navigation is a new innovation that may prove useful in catheter ablation of cardiac arrhythmias and cardiac resynchronization therapy. The ability to steer extremely floppy catheters and guidewires may allow for these to be positio
Externí odkaz:
https://doaj.org/article/c102ded104184d3384ad2a7ac93bcb12
Autor:
Maximo Rivero-Ayerza, Jan Vercammen, Dieter Nuyens, Wilfried Mullens, Evert Luwel, Pieter Martens, Wendy Ceyssens, Matthias Dupont, Hugo Van Herendael
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 108(10)
Sacubitril/valsartan reduced the occurrence of sudden cardiac death in the PARADIGM-HF trial. However, limited information is available about the mechanism. Heart failure (HF)-patients receiving sacubitril/valsartan for a class-I indication equipped
Autor:
Tine Proesmans, Pieter M. Vandervoort, Dieter Nuyens, Johan Vijgen, Maximo Rivero-Ayerza, Frederik H. Verbrugge, Wilfried Mullens, Hugo Van Herendael
Publikováno v:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 21(8)
Aims This cross-sectional study was set up to assess the feasibility of mass screening for atrial fibrillation (AF) with only the use of a smartphone. Methods and results A local newspaper published an article, allowing to subscribe for a 7-day scree
Autor:
Beat Schaer, Christian Sticherling, Frederik H. Verbrugge, Nick van Boven, Maximo Rivero-Ayerza, Victor A. Umans, Marcoen F. Scholten, Dominic A.M.J. Theuns, Tim Hesselink, Felix Zijlstra
Publikováno v:
Journal of Cardiac Failure, 25(10), 812-818. Churchill Livingstone
Background The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have clearly been established. Nevertheless, mortality remains high in
Autor:
Tine Proesmans, T Vanhecke, Bart François, T Boussy, Frank Provenier, Dieter Nuyens, Maximo Rivero-Ayerza, D De Cock, H Van Herendael
Publikováno v:
European Heart Journal. 39
Publikováno v:
Acta cardiologica
Objective: Cardiac involvement in sarcoidosis can present in various ways, with atrioventricular (AV) block and ventricular arrhythmias being the most common signs. Because of initial non-specific findings, diagnosis can be a challenge. Very few data
Autor:
Dirk Stockman, Maximo Rivero-Ayerza, Dietrich Pfeiffer, Norbert Klein, Maika Klein, Martin Hinterseer
Publikováno v:
Archives of Medicine.
Background: In an earlier study comparing acceleration sensor (AS)- and closed loop stimulation (CLS)-based rateadaptive pacing, a sub analysis showed that heart rate (HR) after 6-minute walk (6MW) was higher in symptomatic (NYHA II/III) than symptom
Autor:
Jan Vercammen, Maximo Rivero-Ayerza, David Verhaert, Linda Jacobs, Matthias Dupont, Philip De Vusser, Hugo Van Herendael, Wilfried Mullens, Petra Nijst, Pieter M. Vandervoort, Frederik H. Verbrugge
Publikováno v:
Europace. 16:1197-1204
AIMS: To assess the influence of device-registered episodes of atrial tachyarrhythmia (AT) on the response to cardiac resynchronization therapy (CRT). METHODS AND RESULTS: Consecutive CRT patients without history of atrial fibrillation (AF; n = 118)
Autor:
Frederik H. Verbrugge, Philippe De Vusser, Koen Rondelez, Maximo Rivero-Ayerza, Pieter M. Vandervoort, Hugo Van Herendael, David Verhaert, Mathias Vrolix, Christiaan Van Kerrebroeck, Matthias Dupont, Wilfried Mullens
Publikováno v:
Acta Cardiologica. 68:37-45
OBJECTIVE: Cardiac resynchronization therapy (CRT) is an important treatment modality for heart failure with reduced ejection fraction and ventricular conduction delay. Considering limited health care budgets in an aging population, adding a defibril